ALEXANDRA FORREST: Open Payments
NPI 1568102598 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 48 payments from 14 companies in 2025. Trend: 2023 $721 · 2024 $717 · 2025 $1,435
Food & beverage: $1,435
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $489 |
| GENZYME CORPORATION | 5 | $185 |
| Botanix SB Inc | 5 | $178 |
| Incyte Corporation | 3 | $131 |
| UCB, Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Lilly USA, LLC | 1 | $31 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, SOFDRA, OPZELURA, Bimzelx, COSENTYX, Rhapsido.
Industry payments across FL — which companies pay providers there.
